A Japan-based pharmaceutical company focused on developing and commercializing prescription medicines, with a strategic emphasis on oncology and antibody-drug conjugate (ADC) therapies. Its drug pipeline and partnerships—most notably with AstraZeneca on cancer treatments such as Enhertu—have made it...
4 members of Congress have disclosed 9 trades in Daiichi Sankyo Company, Limited (DSNKY), a Healthcare company. The buy/sell breakdown shows 7 purchases versus 2 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-07-10 | Daniel Goldman | sell | $50K – $100K |
| 2018-09-27 | David P. Roe | buy | $1K – $15K |
| 2018-07-27 | David P. Roe | buy | $1K – $15K |
| 2018-07-19 | David P. Roe | buy | $1K – $15K |
| 2018-06-02 | David P. Roe | buy | $1K – $15K |
| 2018-02-01 | David P. Roe | buy | $1K – $15K |
| 2018-02-01 | David P. Roe | buy | $1K – $15K |
| 2015-03-31 | Harold Dallas Rogers | buy | $15K – $50K |
| 2012-01-10 | MICHAEL T. MCCAUL | sell | $1K – $15K |